3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Lymphatic Metastasis
1
Interventions
Indocyanine Green
7
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
Lymph Node Excision
4
Cisplatin
4
Surgical Procedures, Operative
3
Specimen Handling
3
Radiotherapy, Intensity-Modulated
3
Radiosurgery
3
gadofosveset trisodium
2
Technetium
2
TP protocol
2
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Nivolumab
2
Ipilimumab
2
Electroporation
2
Conversion to Open Surgery
2
Control Groups
2
tislelizumab
1
radium Ra 223 dichloride
1
peposertib
1
pembrolizumab
1
gewf solution
1
encorafenib
1
cabozantinib
1
binimetinib
1
avelumab
1
alovudine
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lymphatic Metastasis
×
PITX2 protein, human
×
Clear all
NCT04300673
2022-04-29
DETECT
Radboud University Medical Center
Phase 1/2
Unknown
20 enrolled